NANETS Transition Update
It has been a little over a month since we established our new headquarters and staff in New York. I'm pleased to report it has been a productive transition which has allowed us to align our organization with many of our strategic goals.
In memoriam Dirk J. Kwekkeboom (1958 - 2017)
Dirk J. Kwekkeboom, MD, widely regarded as one of Europe’s foremost experts on peptide receptor radiotherapy (PRRT), passed away March 8, 2017, at the age of 58.
Beloved by all and affectionately known as Dik, he was just appointed Professor of Nuclear Medicine at the Erasmus University in 2016. Dik was a member of the Advisory Boards of both the European Neuroendocrine Tumor Society (ENETS) and the North American Neuroendocrine Tumors Society (NANETS).
NANETS Welcomes New Management Team
In January, NANETS extended its thanks and gratitude to our outgoing executive director. This month, I share the news that NANETS has established a new office headquarters and staff.
It's been a productive month as leaders and committee chairs work to align new staff with the goals identified in our strategic plan. In making this transition, the Board of Directors has added capacity and created a foundation that will support growth and continue to advance our mission to improve neuroendocrine tumor (NET) disease management through increased research and educational opportunities.